Pfizer Inc., of New York, said the FDA approved expansion of its pneumococcal conjugate vaccine, Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), in older children and adolescents 6 through 17 for active immunization against invasive disease caused by the 13 Streptococcus pneumoniae serotypes contained in the vaccine

Pfizer Inc., of New York, said the Committee for Medicinal Products for Human Use of the European Medicines Agency offered a positive opinion on the conditional marketing authorization of bosutinib in the European Union (EU) in chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia patients previously treated with one or more tyrosine kinase inhibitors and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment

Pfizer Inc., of New York, said the European Commission approved expanding the use of pneumococcal conjugate vaccine Prevener 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) to older children and adolescents, ages 6 to 17, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumoniae

Pfizer Inc., of New York, agreed to pay $25 million to the state of Texas, the U.S

Repligen Corp., of Waltham, Mass., said it entered an exclusive worldwide agreement with Pfizer Inc., of New York, to advance Repligen's spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA

Bristol-Myers Squibb Co., of New York, and Pfizer Inc., of New York, said the FDA approved Eliquis (apixaban) to reduce the risk of stroke and systemic embolism in patients with nanvalvular atrial fibrillation

The Japanese Ministry of Health, Labor, and Welfare approved Eliquis (apixaban) by Bristol-Myers Squibb Co., of Princeton, N.J., and Pfizer Inc., of New York, for prevention of stroke and embolism in patients with nonvalvular atrial fibrillation

Ligand Pharmaceuticals Inc., of San Diego, and Pfizer Inc., of New York, said the FDA accepted for review a new drug application for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms and vulvar and vaginal atrophy associated with menopause, as well as the prevention of postmenopausal osteoporosis

Pfizer Inc., of New York, will pay $55 million plus interest to resolve allegations that Wyeth LLC illegally introduced and caused the introduction into interstate commerce of a misbranded drug, Protonix, between February 2000 and June 2001, the Justice Department reported

Distribution of Prothena ordinary shares in the demerger is conditioned upon, among other conditions to the demerger, a registration statement filed with the SEC, having been declared effective by the SEC and the affirmative vote of the Elan shareholders...Galderma will continue to supply Restylane and Perlane to Valeant under the same terms and conditions that the products are supplied to Medicis, while Valeant will make undisclosed up-front and royalty payments to Galderma on sales of Sculptra...To

Nuron Biotech Inc., of Exton, Pa., acquired a vaccine for Neisseria meningitidis serogroup C meningitis from New York-based Pfizer Inc

Protalix BioTherapeutics Inc., of Carmiel, Israel, signed a clinical development agreement with Pfizer Inc., of New York, to manage, administer and sponsor current, ongoing clinical trials relating to Elelyso (taliglucerase alfa

Pfizer Inc., of New York, said it completed its acquisition of Cupertino, Calif.-based NextWave Pharmaceuticals Inc., a privately held specialty pharma firm developing products for attention deficit hyperactivity disorder (ADHD

Bristol-Myers Squibb Co., of New York, and Pfizer Inc., also of New York, said the European Commission approved Eliquis (apixaban) for prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation with one or more risk factors

The trial is designed to show an overall survival benefit with IMA901 in combination with sunitinib (Sutent, Pfizer Inc.), standard first-line therapy in comparison to sunitinib alone in patients with metastatic and/or locally advanced RCC

received FDA approval on its abbreviated new drug application for sildenafil tablets, 20 mg, the generic equivalent to New York-based Pfizer Inc.'s Revatio, for the treatment of pulmonary arterial hypertension in adults to improve exercise ability and delay clinical worsening

Separately, Auxilium and European partner Pfizer Inc., of New York, said they are amending their collaboration agreement for the development, commercialization and supply of the drug, branded Xiapex in the European Union and certain other European and Eurasian countries

The trial will compare AZD4547 in combination with AstraZeneca's anastrozole (Arimidex) or letrozole (Femara, Novartis AG) to exemestane (Aromasin, Pfizer Inc.) alone...Protalix BioTherapeutics Inc., of Carmiel, Israel, and Pfizer Inc., of New York, said the European Commission refused to grant the marketing authorization application for taliglucerase alfa, an enzyme replacement therapy for Gaucher disease, following a negative recommendation from the Committee for Medicinal Products for Human

Isis Pharmaceuticals Inc., of Carlsbad, Calif., said it will receive a $1.25 million contingent payment from Pfizer Inc., of New York, triggered by Pfizer's decision to advance the antiscarring therapy EXC 001 into a Phase II study